Expansion Opportunity Securecell has recently expanded offices to the Netherlands and Western Europe, indicating growth activity and potential demand for region-specific digitalization, automation, and local partner ecosystems in Benelux and broader European markets.

Automation Focus The company specializes in end-to-end automated bioprocess development and high-throughput systems, presenting a strong upsell path for lab automation, SCADA integrations, PAT tooling, and remote monitoring solutions to biotech labs seeking efficiency gains.

Data & Analytics With capabilities in data management, CPP monitoring, and online analytics integration, Securecell is well-positioned to engage customers needing robust data platforms, visualization, and compliant analytics pipelines in bioprocessing.

Strategic Partnerships Past partnerships with 908 Devices and international collaborators suggest a channel strategy ripe for expanding co-developed solutions, CPP monitoring, and cross-sell of bioprocess sampling, filtration, and automation software.

SME Target Revenue in the low-to-mid multi-million range and a focus on scalable, vendor-neutral SCADA and Ambr-compatible autosampling offer a sweet spot for mid-sized biotech firms seeking cost-effective automation upgrades and faster time-to-value.